U.S. Other Utilities Stock News

NYSE:KKR
NYSE:KKRCapital Markets

Is KKR’s (KKR) Samsung SDS AI Bet Quietly Rewriting Its Technology Investment Playbook?

In recent days, KKR entered into a partnership with Samsung SDS, with KKR-managed funds committing KRW 1.22 trillion (about US$820 million) in newly issued convertible bonds to support Samsung SDS’s AI-focused infrastructure and global expansion plans. This move, alongside the earlier final close of KKR’s approximately US$23.00 billion North America Fund XIV, highlights how the firm is reinforcing both its capital base and its role as an active partner in technology-enabled growth. We’ll now...
NYSE:UPS
NYSE:UPSLogistics

Is It Time To Revisit UPS (UPS) After Recent Share Price Recovery?

If you are wondering whether United Parcel Service (UPS) is fairly priced or offering value right now, this breakdown will help you frame the stock through several valuation lenses. UPS recently closed at US$103.22, with returns of 5.8% over 7 days, 6.2% over 30 days, 2.2% year to date and 14.3% over 1 year, set against weaker 3 year and 5 year returns of 37.7% and 28.9% declines. These mixed return figures sit alongside ongoing attention on parcel volumes, pricing power and cost control,...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

Is Hiring AI-Focused Rare Disease R&D Leader Sandeep Menon Altering The Investment Case For BioCryst (BCRX)?

Earlier this month, BioCryst Pharmaceuticals, Inc. appointed Sandeep M. Menon, MD, PhD, a veteran of Alnylam and Pfizer, as Chief Research and Development Officer, bringing extensive experience in global clinical development, biostatistics and rare disease drug approvals. His background in advancing complex therapies like RNAi drugs and leading AI-enabled R&D organizations may meaningfully influence how BioCryst prioritizes and executes its future development pipeline. Next, we’ll explore...
NYSE:FN
NYSE:FNElectronic

Is Fabrinet (FN) Still Attractive After A 262% One Year Share Price Surge

If you are trying to figure out whether Fabrinet's share price reflects its real worth, this is the place to start. The stock last closed at US$681.68, with returns of 22.2% over 7 days, 35.8% over 30 days, 42.2% year to date, 261.6% over 1 year, 603.2% over 3 years, and a very large gain over 5 years. Recent coverage of Fabrinet has focused on its role in high performance optical and electronic manufacturing, as customers look for partners that can handle complex, high value hardware. This...
NYSE:SMG
NYSE:SMGChemicals

How Investors May Respond To Scotts Miracle-Gro (SMG) Reaffirming 2026 Guidance Amid Commodity Disruptions

Earlier in fiscal 2026, Scotts Miracle-Gro reaffirmed its full-year guidance, saying the Iran War’s commodity disruptions should not affect its outlook, after securing over 80% of its commodity needs and sourcing roughly 90% of product costs domestically under existing contracts. The company also issued fiscal 2026 EPS guidance of US$4.15 to US$4.35, highlighting management’s confidence in gross margin recovery and growth plans despite external supply and cost uncertainties. Now we’ll...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Assessing Sigma Lithium (SGML) Valuation After EV Demand Tailwinds And US$100 Million Plant Financing

Fresh capital and two-year high put Sigma Lithium in focus Sigma Lithium (SGML) is back on investor radars after securing a US$100 million collateralized bank guarantee for its Greentech Industrial Plant 2, alongside a recent move to a new two year share price high. See our latest analysis for Sigma Lithium. The recent move to a US$17.57 share price comes alongside a 58.72% 1 month share price return and 23.65% year to date share price return. The 1 year total shareholder return of 118.80%...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

AI Recoupment Tool Built On 7.5 Billion Transactions Might Change The Case For Investing In Waystar Holding (WAY)

Earlier this month, Waystar announced an AI-powered recoupments solution, using its AltitudeAI platform and a dataset of over 7.50 billion healthcare payment transactions and US$2.40 trillion in annual gross claims, to uncover provider revenue quietly taken back through opaque post-payment adjustments. In early adopter deployments, the tool has cut reconciliation time by more than 80% and, for a health system with about US$4.00 billion in annual revenue, identified US$32.00 million in...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

Did PayPal’s (PYPL) Canva Integration Quietly Recast Its Role in the Creator Economy?

In early April 2026, Canva announced that PayPal Payment Links is now available directly within its platform, allowing 265 million monthly users to turn any digital or printed design into a PayPal-hosted checkout experience with links or QR codes, multiple currencies, and no website required. This integration highlights how PayPal is embedding payments into creative workflows, potentially deepening its reach among creators, entrepreneurs, and small businesses that monetize content across...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

A Look At JOYY (JOYY) Valuation As BIGO Ads Gains Global ROI Recognition

BIGO Ads, the AI-powered advertising platform under JOYY (NasdaqGS:JOYY), has been ranked among the Top 15 Growth Ad Partners on Singular’s Global ROI Index 2026, alongside multiple regional Android gaming distinctions. See our latest analysis for JOYY. That recognition for BIGO Ads comes as JOYY’s share price, now at US$62.16, reflects mixed momentum. A 6.02% 7 day share price return has been offset by an 11.10% 90 day share price decline, while longer term total shareholder returns over one...
NYSE:AX
NYSE:AXBanks

Axos Financial (AX) Downgrade: Does Valuation Now Overshadow Its Earlier Growth-Focused Story?

Recently, Zacks Research downgraded Axos Financial from a "strong buy" to a "hold" rating, pointing to valuation concerns after a period of strong operating performance and analyst attention. This shift in sentiment comes despite Axos’s multi-year gains in net interest income and earnings per share, highlighting a tension between its business momentum and how the market now views its valuation. We'll now examine how this valuation-driven downgrade interacts with Axos Financial's earlier...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet Faces Omnipod 5 Correction While Shares Trade Below Targets

Insulet (NasdaqGS:PODD) issued a voluntary medical device correction for select Omnipod 5 batches in the U.S. tied to a manufacturing flaw in internal insulin delivery tubing. The company flagged that the defect could disrupt insulin delivery and pose serious health risks for users. Insulet is updating quality control processes and continuing customer shipments while addressing affected lots. Insulet focuses on insulin delivery technology through its Omnipod franchise, which is closely...
NYSE:NEE
NYSE:NEEElectric Utilities

Is It Too Late To Consider NextEra Energy (NEE) After Its 39% One Year Rally?

Wondering if NextEra Energy is still reasonably priced after its recent run, or if you might be looking at a stock that is already reflecting a lot of good news? The share price closed at US$91.31, with returns of 12.8% year to date and 39.0% over the last year. This raises fair questions about how much value is already priced in. Recent headlines have focused on NextEra Energy as a large US utilities name that investors often watch closely when sentiment shifts around interest rates and...
NYSE:BE
NYSE:BEElectrical

US Stock Market Today: S&P 500 Futures Edge Higher As Jobs Stay Strong And Inflation Cools

The Morning Bull - US Market Morning Update Wednesday, Apr, 15 2026 US stock futures are slightly higher this morning, with S&P 500 contracts inching up about 0.05%, as investors weigh strong hiring against cooler inflation. Fresh figures from ADP show private employers adding an average of 39,250 jobs per week in late March, which suggests the job market is still creating work and can support spending. At the same time, core producer prices, a key measure of business cost pressures, rose...
NYSE:SOC
NYSE:SOCOil and Gas

Sable Offshore (SOC) Is Down 11.1% After Santa Ynez Output Restarts Top 60,000 Barrels Per Day

Sable Offshore Corp. recently began selling oil from its Santa Ynez pipeline system in California, with Platform Harmony producing about 22,000 gross barrels per day and phased restarts underway at Platforms Heritage and Hondo that are expected to lift total unit output above 60,000 barrels per day. This restart marks a key operational turning point for Sable Offshore, as it moves from long-running restart efforts to active, integrated production across the Santa Ynez Unit. Next, we’ll...
NYSE:PSX
NYSE:PSXOil and Gas

Phillips 66 Weighs Renewables Shift And California Pipeline Against Future Returns

Phillips 66 (NYSE:PSX) CEO has outlined a shift towards renewables, including advancing the conversion of the Rodeo refinery into a renewables facility. The company plans to use non fossil feedstocks and expand its role in California's fuel markets. A new Western Gateway Pipeline project has been proposed to support fuel supply into California and address regional constraints. For investors watching NYSE:PSX, this update adds detail on how Phillips 66 is positioning itself in the energy...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

How Yen Bond Issuance And Antitrust Scrutiny At Berkshire Hathaway (BRK.A) Has Changed Its Investment Story

In early April 2026, Berkshire Hathaway Inc. completed multiple senior unsecured fixed-rate Eurobond offerings in Japan totaling about ¥272.3 billion, with maturities ranging from 2029 to 2056. At the same time, a federal judge ordered Berkshire’s HomeServices of America unit to face an antitrust lawsuit over alleged commission inflation, spotlighting both its global funding approach and legal exposure in real estate brokerage. We’ll now examine how Berkshire’s sizeable yen bond issuance...
NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global Expands AI Energy Insights While Mobility Tracks Used Car Volatility

S&P Global (NYSE:SPGI) has completed the acquisition of Enertel AI Corporation. The deal adds AI driven short term power price forecasting to S&P Global's energy division. The move comes as its Mobility unit continues to track volatility in the used car market. S&P Global, known for its credit ratings, benchmarks, and data intelligence, is leaning further into energy analytics with the Enertel AI acquisition. By folding Enertel's forecasting tools into its energy division, the company is...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Can Synopsys (SNPS) NASA Simulation Work Deepen Its Systems Engineering Edge In Mission-Critical Markets?

NASA previously selected Synopsys, EMA, and Cesium (part of Bentley Systems) to use advanced simulation and digital twin tools to verify Artemis spacesuit safety and lunar communications performance under harsh plasma, regolith, and terrain conditions. This work highlights Synopsys’ role in mission-critical engineering for aerospace, extending its silicon-to-systems capabilities into high-stakes government applications such as lunar EVA and connectivity planning. Next, we’ll examine how...
NYSE:LC
NYSE:LCConsumer Finance

Assessing LendingClub (LC) Valuation As Insider Selling And Profit Concerns Prompt Investor Caution

Event overview: why LendingClub is drawing attention now LendingClub (LC) is back in focus after recent analysis flagged the shares as trading above intrinsic value, alongside insider sales over the past 3 months and questions around profitability and long term growth. See our latest analysis for LendingClub. LendingClub’s share price has recently moved to US$15.85, with a 1 month share price return of 14.86% and a 1 year total shareholder return of 67.72%. However, the 3 month share price...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

A Look At Agios Pharmaceuticals (AGIO) Valuation As PYRUKYND Growth Prospects Face Mixed Signals

Agios Pharmaceuticals (AGIO) focuses on treatments for rare blood disorders, with lead product PYRUKYND targeting pyruvate kinase deficiency and sickle cell disease. This provides a starting point for assessing how current revenue and losses relate to its market value. See our latest analysis for Agios Pharmaceuticals. Recent momentum has been mixed, with the share price at $33.30 after a 19.57% 1 month share price return and a 15.91% 3 month share price return, while the 1 year total...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Its Mixed Share Price Performance?

If you are wondering whether Natera's current share price reflects its true worth, this article walks through the key numbers that matter before you commit fresh capital. Over the last week the stock returned 2.6%, over the last month 14.3%, while year to date it is down 6.2% and the 1 year return sits at 41.5%. This gives a mixed picture of momentum and risk sentiment around the current US$214.64 share price. Recent coverage has focused on Natera's position in diagnostics and its progress...
NYSE:UNP
NYSE:UNPTransportation

Assessing Union Pacific’s (UNP) Valuation As Recent Share Price Momentum Draws Fresh Attention

How Union Pacific’s Recent Performance Frames the Investment Debate Union Pacific (UNP) has drawn fresh attention as its shares recently changed hands at around $252, with returns over the past month and past 3 months outpacing its year to date move. That backdrop, alongside a value score of 5 and an indicated intrinsic discount of about 21%, is prompting investors to reassess how the railroad’s current price reflects its earnings profile and business mix. See our latest analysis for Union...
NYSE:BORR
NYSE:BORREnergy Services

Is It Too Late To Consider Borr Drilling (NYSE:BORR) After Its 203% One Year Rally?

For investors considering whether Borr Drilling at around US$5.70 offers further upside or if expectations are already reflected in the price, a useful starting point is understanding what the current market price implies about value. The stock has seen mixed recent returns, with about a 4.5% decline over the last 7 days, a 12.6% gain over 30 days, and a 42.9% gain year to date. The 1 year return of 203.2% contrasts with a 3 year return reflecting a 19.1% decline and a 5 year return of...